KNEAT.COM INC (KSI.CA) Stock Fundamental Analysis
Canada - TSX:KSI - CA4988241010 - Common Stock
5.39 CAD
+0.13 (+2.47%)
KSI gets a fundamental rating of 5 out of 10. The analysis compared the fundamentals against 8 industry peers in the Health Care Technology industry. Both the profitability and the financial health of KSI get a neutral evaluation. Nothing too spectacular is happening here. KSI is valued quite expensively, but it does show have an excellent growth rating.
1. Profitability
1.1 Basic Checks
KSI had negative earnings in the past year.
In the past year KSI had a positive cash flow from operations.
In the past 5 years KSI always reported negative net income.
The reported operating cash flow has been mixed in the past 5 years: KSI reported negative operating cash flow in multiple years.
1.2 Ratios
With an excellent Return On Assets value of 0.35%, KSI belongs to the best of the industry, outperforming 88.89% of the companies in the same industry.
KSI has a Return On Equity of 0.72%. This is amongst the best in the industry. KSI outperforms 88.89% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 0.35% | ||
| ROE | 0.72% | ||
| ROIC | N/A |
ROA(3y)-15.47%
ROA(5y)-16.49%
ROE(3y)-45.71%
ROE(5y)-39.12%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
KSI has a better Profit Margin (0.84%) than 88.89% of its industry peers.
KSI's Gross Margin of 75.35% is fine compared to the rest of the industry. KSI outperforms 77.78% of its industry peers.
In the last couple of years the Gross Margin of KSI has grown nicely.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | 0.84% | ||
| GM | 75.35% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y7.7%
GM growth 5Y11.01%
2. Health
2.1 Basic Checks
KSI does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, KSI has more shares outstanding
Compared to 5 years ago, KSI has more shares outstanding
Compared to 1 year ago, KSI has an improved debt to assets ratio.
2.2 Solvency
An Altman-Z score of 4.29 indicates that KSI is not in any danger for bankruptcy at the moment.
KSI has a Altman-Z score (4.29) which is in line with its industry peers.
KSI has a Debt/Equity ratio of 0.37. This is a healthy value indicating a solid balance between debt and equity.
KSI has a Debt to Equity ratio of 0.37. This is comparable to the rest of the industry: KSI outperforms 55.56% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.37 | ||
| Debt/FCF | N/A | ||
| Altman-Z | 4.29 |
ROIC/WACCN/A
WACC7.37%
2.3 Liquidity
A Current Ratio of 1.81 indicates that KSI should not have too much problems paying its short term obligations.
The Current ratio of KSI (1.81) is better than 88.89% of its industry peers.
A Quick Ratio of 1.81 indicates that KSI should not have too much problems paying its short term obligations.
With an excellent Quick ratio value of 1.81, KSI belongs to the best of the industry, outperforming 88.89% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.81 | ||
| Quick Ratio | 1.81 |
3. Growth
3.1 Past
The Earnings Per Share has grown by an impressive 100.00% over the past year.
The Revenue has grown by 39.32% in the past year. This is a very strong growth!
Measured over the past years, KSI shows a very strong growth in Revenue. The Revenue has been growing by 65.43% on average per year.
EPS 1Y (TTM)100%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%100%
Revenue 1Y (TTM)39.32%
Revenue growth 3Y46.7%
Revenue growth 5Y65.43%
Sales Q2Q%31.94%
3.2 Future
Based on estimates for the next years, KSI will show a very strong growth in Earnings Per Share. The EPS will grow by 41.08% on average per year.
KSI is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 30.40% yearly.
EPS Next Y72.23%
EPS Next 2Y11.01%
EPS Next 3Y41.08%
EPS Next 5YN/A
Revenue Next Year31.7%
Revenue Next 2Y30.59%
Revenue Next 3Y29.24%
Revenue Next 5Y30.4%
3.3 Evolution
The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
4. Valuation
4.1 Price/Earnings Ratio
KSI is expected to report negative earnings next year, which makes the Forward Price/Earnings Ratio negative.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A |
4.2 Price Multiples
Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of KSI indicates a rather cheap valuation: KSI is cheaper than 88.89% of the companies listed in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | 93.07 |
4.3 Compensation for Growth
KSI's earnings are expected to grow with 41.08% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y11.01%
EPS Next 3Y41.08%
5. Dividend
5.1 Amount
KSI does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
TSX:KSI (10/31/2025, 7:00:00 PM)
5.39
+0.13 (+2.47%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Technology
Earnings (Last)
Earnings (Next)
Inst Owners15.82%
Inst Owner ChangeN/A
Ins Owners9.89%
Ins Owner ChangeN/A
Market Cap513.18M
Revenue(TTM)56.65M
Net Income(TTM)476.70K
Analysts80
Price Target8.06 (49.54%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)139.6%
Min EPS beat(2)100%
Max EPS beat(2)179.21%
EPS beat(4)4
Avg EPS beat(4)100.76%
Min EPS beat(4)0.99%
Max EPS beat(4)179.21%
EPS beat(8)8
Avg EPS beat(8)55.69%
EPS beat(12)11
Avg EPS beat(12)42.49%
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-5%
Min Revenue beat(2)-5.77%
Max Revenue beat(2)-4.23%
Revenue beat(4)1
Avg Revenue beat(4)-2.31%
Min Revenue beat(4)-5.77%
Max Revenue beat(4)2.47%
Revenue beat(8)3
Avg Revenue beat(8)-1.06%
Revenue beat(12)5
Avg Revenue beat(12)-0.58%
Revenue beat(16)9
Avg Revenue beat(16)3.48%
PT rev (1m)0%
PT rev (3m)-3.66%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-49.98%
EPS NY rev (1m)0%
EPS NY rev (3m)66.67%
Revenue NQ rev (1m)0.15%
Revenue NQ rev (3m)-1.85%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-5%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A | ||
| P/S | 9.06 | ||
| P/FCF | N/A | ||
| P/OCF | 33.52 | ||
| P/B | 7.73 | ||
| P/tB | 21.05 | ||
| EV/EBITDA | 93.07 |
EPS(TTM)0
EYN/A
EPS(NY)-0.08
Fwd EYN/A
FCF(TTM)-0.06
FCFYN/A
OCF(TTM)0.16
OCFY2.98%
SpS0.59
BVpS0.7
TBVpS0.26
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 0.35% | ||
| ROE | 0.72% | ||
| ROCE | N/A | ||
| ROIC | N/A | ||
| ROICexc | N/A | ||
| ROICexgc | N/A | ||
| OM | N/A | ||
| PM (TTM) | 0.84% | ||
| GM | 75.35% | ||
| FCFM | N/A |
ROA(3y)-15.47%
ROA(5y)-16.49%
ROE(3y)-45.71%
ROE(5y)-39.12%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y7.7%
GM growth 5Y11.01%
F-Score7
Asset Turnover0.42
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.37 | ||
| Debt/FCF | N/A | ||
| Debt/EBITDA | 4.73 | ||
| Cap/Depr | 179.9% | ||
| Cap/Sales | 36.81% | ||
| Interest Coverage | N/A | ||
| Cash Conversion | 298.64% | ||
| Profit Quality | N/A | ||
| Current Ratio | 1.81 | ||
| Quick Ratio | 1.81 | ||
| Altman-Z | 4.29 |
F-Score7
WACC7.37%
ROIC/WACCN/A
Cap/Depr(3y)219.46%
Cap/Depr(5y)224.77%
Cap/Sales(3y)49.12%
Cap/Sales(5y)62.1%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)100%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%100%
EPS Next Y72.23%
EPS Next 2Y11.01%
EPS Next 3Y41.08%
EPS Next 5YN/A
Revenue 1Y (TTM)39.32%
Revenue growth 3Y46.7%
Revenue growth 5Y65.43%
Sales Q2Q%31.94%
Revenue Next Year31.7%
Revenue Next 2Y30.59%
Revenue Next 3Y29.24%
Revenue Next 5Y30.4%
EBIT growth 1Y41.86%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year214.46%
EBIT Next 3Y76.25%
EBIT Next 5Y48.14%
FCF growth 1Y55.15%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y349.62%
OCF growth 3Y61.83%
OCF growth 5YN/A
KNEAT.COM INC / KSI.CA FAQ
What is the fundamental rating for KSI stock?
ChartMill assigns a fundamental rating of 5 / 10 to KSI.CA.
Can you provide the valuation status for KNEAT.COM INC?
ChartMill assigns a valuation rating of 2 / 10 to KNEAT.COM INC (KSI.CA). This can be considered as Overvalued.
What is the profitability of KSI stock?
KNEAT.COM INC (KSI.CA) has a profitability rating of 4 / 10.
How financially healthy is KNEAT.COM INC?
The financial health rating of KNEAT.COM INC (KSI.CA) is 5 / 10.